Income Statement ATON Deutsche Boerse AG

Stocks

3HB

FR0004153930

Advanced Medical Equipment & Technology

Delayed Deutsche Boerse AG Other stock markets 07:08:16 26/06/2026 BST			5-day change	1st Jan Change
0.006000 ^EUR	+36.36%		-48.84%	+69.23%

03-20	ATON Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-18	Aton Group Appoints Hadrien Lanvin as Deputy CEO	CI

ed516bd6d6a3b37875954e67fa28eec6.H4IXa90RwGQdHDeMk3iW3EhbRYEZB6YjQuXX6XjDqqE.e-5kOoh9i1ZrJAH6_jGvjWUiIPdAdfxqF5azsRWx4cplzSEIuHO2BlJlBw

Published financial data: ATON

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-96	-	1.56K	382K	614K
Other Revenues, Total	-	-	-1	-	-
Total Revenues	-96	-	1.56K	382K	614K
Cost of Goods Sold, Total	236K	257K	212K	530K	237K
Gross Profit	-236K	-257K	-211K	-148K	377K
Selling General & Admin Expenses, Total	210K	-	373K	559K	972K
Depreciation & Amortization - (IS)	10.17K	7.14K	8.12K	48.23K	794K
Other Operating Expenses	-140K	-140K	-1.17K	-1.92K	-11K
Other Operating Expenses, Total	80.95K	-133K	379K	605K	1.76M
Operating Income	-317K	-123K	-590K	-753K	-1.38M
Interest Expense, Total	-2.42K	-21.68K	-56.57K	-133K	-256K
Interest And Investment Income	35.51K	52.75K	77.16K	254K	-
Net Interest Expenses	33.1K	31.07K	20.59K	121K	-256K
Income (Loss) On Equity Invest.	-	-	-	-	-30K
Currency Exchange Gains (Loss)	-960	1.28K	-2.88K	-5	-
Other Non Operating Income (Expenses)	3.77K	1	-1	-12.88M	-2K
EBT, Excl. Unusual Items	-281K	-90.94K	-572K	-13.51M	-1.67M
Gain (Loss) On Sale Of Investments	-	388K	-	-	-275K
Asset Writedown	-97.48K	-	-	-	-
Other Unusual Items	52K	-366K	8.87K	-5.34M	839K
EBT, Incl. Unusual Items	-327K	-69.16K	-564K	-18.85M	-1.1M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-327K	-69.16K	-564K	-18.85M	-1.1M
Net Income to Company	-327K	-69.16K	-564K	-18.85M	-1.1M
Minority Interest	-	-	-	-	1K
Net Income - (IS)	-327K	-69.16K	-564K	-18.85M	-1.1M
Net Income to Common Incl Extra Items	-327K	-69.16K	-564K	-18.85M	-1.1M
Net Income to Common Excl. Extra Items	-327K	-69.16K	-564K	-18.85M	-1.1M
Per Share Items
Net EPS - Basic	-0	-0	-	-0.05	-0
Basic EPS - Continuing Operations	-0	-0	-	-0.05	-0
Basic Weighted Average Shares Outstanding	234M	261M	-	383M	585M
Net EPS - Diluted	-0	-0	-	-0.05	-0
Diluted EPS - Continuing Operations	-0	-0	-	-0.05	-0
Diluted Weighted Average Shares Outstanding	234M	261M	-	383M	585M
Normalized Basic EPS	-0	-0	-	-0.02	-0
Normalized Diluted EPS	-0	-0	-	-0.02	-0
Supplemental Items
EBITDA	-307K	-116K	-582K	-705K	-1.18M
EBITA	-317K	-123K	-590K	-753K	-1.36M
EBIT	-317K	-123K	-590K	-753K	-1.38M
EBITDAR	-	-	-	-	-1.12M
Total Revenues (As Reported)	235K	153K	4.23K	389K	-
Effective Tax Rate - (Ratio)	-	-	-	-	-
Normalized Net Income	-176K	-56.84K	-358K	-8.44M	-1.04M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	52K
Selling and Marketing Expenses	-	-	-	-	52K
Research And Development Expense From Footnotes	-	-	-	-	338K
Net Rental Expense, Total	-	-	-	-	60K
Imputed Operating Lease Interest Expense	-	-	-	-	21.31K
Imputed Operating Lease Depreciation	-	-	-	-	38.69K
Maintenance & Repair Expenses, Total	-	-	-	-	114K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	-	1.54M	598K	958	84K
Total Cash And Short Term Investments	-	1.54M	598K	958	84K
Accounts Receivable, Total	99.61K	84.9K	6.68K	306K	182K
Other Receivables	3.86M	2.87M	4.14M	353K	1.04M
Notes Receivable	-	-	-	-	8K
Total Receivables	3.96M	2.95M	4.14M	659K	1.23M
Prepaid Expenses	-	1K	1K	6.6K	35K
Other Current Assets, Total	5K	-	6.21K	6.21K	-
Total Current Assets	3.97M	4.49M	4.75M	673K	1.35M
Gross Property Plant And Equipment	76.22K	76.22K	83.94K	83.94K	5.77M
Accumulated Depreciation	-48.5K	-55.64K	-63.65K	-72K	-2.17M
Net Property Plant And Equipment	27.71K	20.58K	20.3K	11.95K	3.59M
Long-term Investments	2.42M	8.64M	10.14M	0	112K
Other Intangibles, Total	0	0	295K	346K	399K
Loans Receivable Long-Term	-	-	-	-	13K
Deferred Charges Long-Term	-	-	-	-	983K
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	6.42M	13.15M	15.2M	1.03M	6.45M
Liabilities
Accounts Payable, Total	418K	235K	457K	430K	275K
Accrued Expenses, Total	10.86K	5.69K	-	-	182K
Short-term Borrowings	91	902K	-	3.67K	89K
Current Portion of Long-Term Debt	68.39K	68.39K	-	-	1.93M
Current Portion of Leases	-	-	-	-	289K
Current Income Taxes Payable	535	535	41.3K	73.2K	-
Other Current Liabilities	1.02M	2.51M	-	-	156K
Total Current Liabilities	1.52M	3.72M	498K	507K	2.92M
Long-Term Debt	-	-	2.24M	3.24M	746K
Long-Term Leases	-	-	-	-	1.6M
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	2.23M	1.97M	6K
Total Liabilities	1.52M	3.72M	4.97M	5.72M	5.27M
Common Stock, Total	2.34M	2.61M	2.74M	3.83M	8M
Additional Paid In Capital	3.63M	7.95M	9.19M	12.02M	11.99M
Retained Earnings	-1.06M	-1.13M	-1.69M	-20.54M	-19.2M
Comprehensive Income and Other	-	-	-	-	-6K
Total Common Equity	4.9M	9.43M	10.23M	-4.69M	791K
Minority Interest	-	-	-	-	388K
Total Equity	4.9M	9.43M	10.23M	-4.69M	1.18M
Total Liabilities And Equity	6.42M	13.15M	15.2M	1.03M	6.45M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	234M	261M	-	383M	800M
ECS Total Common Shares Outstanding	234M	261M	-	383M	800M
Book Value / Share	0.02	0.04	-	-0.01	0
Tangible Book Value	4.9M	9.43M	9.94M	-5.03M	392K
Tangible Book Value Per Share	0.02	0.04	-	-0.01	0
Total Debt	68.48K	971K	2.24M	3.24M	4.65M
Net Debt	68.48K	-570K	1.64M	3.24M	4.57M
Debt Equivalent Oper. Leases	-	-	-	-	480K
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	388K
Equity Method Investments, Total	-	-	-	-	112K
Account Code - Inventory Valuation	3	3	3	3	5
Machinery, Total	76.22K	76.22K	83.94K	83.94K	991K
Full Time Employees	-	-	7	3	9
Accumulated Allowance for Doubtful Accounts (Supple)	48.08K	42.53K	42.53K	42.53K	180K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-	-	-	-	-1.1M
Depreciation & Amortization - CF	-	-	-	-	349K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	16K
Depreciation & Amortization, Total	-	-	-	-	365K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	429K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	256K
(Income) Loss On Equity Investments - (CF)	-	-	-	-	30K
Other Operating Activities, Total	-	-	-	-	-363K
Change In Accounts Receivable	-	-	-	-	1.24M
Change In Accounts Payable	-	-	-	-	-159K
Change in Unearned Revenues	-	-	-	-	-191K
Cash from Operations	-	-	-	-	510K
Capital Expenditure	-	-	-	-	-482K
Sale of Property, Plant, and Equipment	-	-	-	-	22K
Divestitures	-	-	-	-	20K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	2K
Cash from Investing	-	-	-	-	-438K
Long-Term Debt Issued, Total	-	-	-	-	721K
Total Debt Issued	-	-	-	-	721K
Long-Term Debt Repaid, Total	-	-	-	-	-625K
Total Debt Repaid	-	-	-	-	-625K
Other Financing Activities, Total	-	-	-	-	-256K
Cash from Financing	-	-	-	-	-160K
Net Change in Cash	-	-	-	-	-88K
Supplemental Items
Cash Interest Paid	-	-	-	-	256K
Levered Free Cash Flow	-	-	-	-	-3.08M
Unlevered Free Cash Flow	-	-	-	-	-2.92M
Change In Net Working Capital	-316K	-2.32M	942K	-3.48M	2.37M
Net Debt Issued / Repaid	-	-	-	-	96K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-3.21	-0.79	-2.6	-5.8	-10.62
Return on Total Capital	-3.86	-1	-3.23	-8.54	-15.89
Return On Equity %	-6.45	-0.96	-5.73	-679.52	319.88
Return on Common Equity	-6.45	-0.96	-5.73	-679.52	168.61
Margin Analysis
Gross Profit Margin %	246K	-	-13.51K	-38.74	61.4
SG&A Margin	-219K	-	23.9K	146.23	158.31
EBITDA Margin %	320K	-	-37.33K	-184.47	-191.46
EBITA Margin %	330K	-	-37.85K	-197.09	-221.82
EBIT Margin %	330K	-	-37.85K	-197.09	-224.43
Income From Continuing Operations Margin %	340K	-	-36.15K	-4.93K	-179.48
Net Income Margin %	340K	-	-36.15K	-4.93K	-179.32
Net Avail. For Common Margin %	340K	-	-36.15K	-4.93K	-179.32
Normalized Net Income Margin	183K	-	-22.95K	-2.21K	-169.42
Levered Free Cash Flow Margin	-	-	-	-	-502.16
Unlevered Free Cash Flow Margin	-	-	-	-	-476.1
Asset Turnover
Asset Turnover	-0	-	0	0.05	0.08
Fixed Assets Turnover	-0	-	0.08	23.7	0.16
Receivables Turnover (Average Receivables)	-0	-	0.03	2.44	1.49
Short Term Liquidity
Current Ratio	2.61	1.21	9.53	1.33	0.46
Quick Ratio	2.61	1.21	9.52	1.3	0.45
Operating Cash Flow to Current Liabilities	-	-	-	-	0.17
Days Sales Outstanding (Average Receivables)	-368K	-	10.71K	149.47	246.19
Average Days Payable Outstanding	686.03	464.78	594.78	305.17	-
Long Term Solvency
Total Debt/Equity	1.4	10.29	21.87	-69.18	394.66
Total Debt / Total Capital	1.38	9.33	17.94	-224.45	79.78
LT Debt/Equity	-	-	21.87	-69.1	198.73
Long-Term Debt / Total Capital	-	-	17.94	-224.2	40.17
Total Liabilities / Total Assets	23.64	28.28	32.69	554.52	81.72
EBIT / Interest Expense	-131.2	-5.69	-10.43	-5.66	-5.38
EBITDA / Interest Expense	-126.99	-5.36	-10.29	-5.3	-3.14
(EBITDA - Capex) / Interest Expense	-126.99	-5.36	-10.29	-5.3	-5.03
Total Debt / EBITDA	-0.22	-8.36	-3.84	-4.6	-5.78
Net Debt / EBITDA	-0.22	4.91	-2.82	-4.6	-5.68
Total Debt / (EBITDA - Capex)	-0.22	-8.36	-3.84	-4.6	-3.62
Net Debt / (EBITDA - Capex)	-0.22	4.91	-2.82	-4.6	-3.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-100.04	-	-	24.4K	0.33
Gross Profit, 1 Yr. Growth %	-58.43	8.62	-17.88	-29.73	-11.71
EBITDA, 1 Yr. Growth %	-76.76	-62.16	401.06	21.12	-15.06
EBITA, 1 Yr. Growth %	-76.69	-61.12	378.65	27.63	-5.29
EBIT, 1 Yr. Growth %	-76.69	-61.12	378.65	27.63	-34.6
Earnings From Cont. Operations, 1 Yr. Growth %	-55.58	-78.83	714.89	3.24K	-86
Net Income, 1 Yr. Growth %	-55.58	-78.83	714.89	3.24K	-86.01
Normalized Net Income, 1 Yr. Growth %	-81.64	-67.66	-292.96	2.26K	-79.37
Diluted EPS Before Extra, 1 Yr. Growth %	-55.59	-81.1	-	-	-92.39
Accounts Receivable, 1 Yr. Growth %	6.34	-14.77	-92.14	4.49K	-71.74
Net Property, Plant and Equip., 1 Yr. Growth %	-23.81	-25.75	-1.35	-41.15	-7.01
Total Assets, 1 Yr. Growth %	8.62	104.8	15.59	-93.22	-33.91
Tangible Book Value, 1 Yr. Growth %	-6.25	92.36	5.37	-150.63	-114.09
Common Equity, 1 Yr. Growth %	-6.25	92.36	8.5	-145.79	-137.72
Cash From Operations, 1 Yr. Growth %	-	-	-	-	-114.9
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	215.03
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	-	-166.95
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	-	-163.2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-96.46	-	302.98	-	1.88K
Gross Profit, 2 Yr. CAGR %	-79.64	-32.81	-5.55	-24.03	33.78
EBITDA, 2 Yr. CAGR %	-79.66	-70.34	37.7	146.35	42.12
EBITA, 2 Yr. CAGR %	-79.41	-69.9	36.42	147.16	51.92
EBIT, 2 Yr. CAGR %	-79.41	-69.9	36.42	147.16	52.81
Earnings From Cont. Operations, 2 Yr. CAGR %	-79.17	-69.34	31.34	1.55K	39.84
Net Income, 2 Yr. CAGR %	-79.17	-69.34	31.34	1.55K	39.77
Normalized Net Income, 2 Yr. CAGR %	-80.85	-75.63	42.68	574.85	70.52
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-71.03	-	1.26K	-
Accounts Receivable, 2 Yr. CAGR %	15.33	-4.8	-74.11	89.94	422.13
Net Property, Plant and Equip., 2 Yr. CAGR %	-24.38	-24.79	-14.41	-23.8	1.23K
Total Assets, 2 Yr. CAGR %	26.79	49.15	53.86	-72	-34.86
Tangible Book Value, 2 Yr. CAGR %	95.58	34.29	42.36	-26.96	-80.14
Common Equity, 2 Yr. CAGR %	95.58	34.29	44.47	-29.51	-72.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-81.21	1.48K	-
Gross Profit, 3 Yr. CAGR %	-	-64.42	-28.16	-14.42	13.7
EBITDA, 3 Yr. CAGR %	-	-74.98	-23.9	31.94	116.3
EBITA, 3 Yr. CAGR %	-	-74.55	-24.3	33.42	122.71
EBIT, 3 Yr. CAGR %	-	-74.55	-24.3	33.42	123.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-79.06	-8.49	286.4	151.64
Net Income, 3 Yr. CAGR %	-	-79.06	-8.49	286.4	151.56
Normalized Net Income, 3 Yr. CAGR %	-	-77.19	-27.97	263.54	77.69
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	227.76	96.4
Accounts Receivable, 3 Yr. CAGR %	-	4.27	-58.54	45.42	28.94
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-24.84	-17.67	-24.46	458.94
Total Assets, 3 Yr. CAGR %	-	48.76	37	-45.65	-21.13
Tangible Book Value, 3 Yr. CAGR %	-	94.5	23.86	0.87	-65.36
Common Equity, 3 Yr. CAGR %	-	94.5	25.08	-1.5	-56.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	37.86	21.18
Gross Profit, 5 Yr. CAGR %	-	-	-	-51.81	-7.87
EBITDA, 5 Yr. CAGR %	-	-	-	-37.54	-2.3
EBITA, 5 Yr. CAGR %	-	-	-	-36.81	0.02
EBIT, 5 Yr. CAGR %	-	-	-	-36.81	0.26
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	20.14	8.42
Net Income, 5 Yr. CAGR %	-	-	-	20.14	8.4
Normalized Net Income, 5 Yr. CAGR %	-	-	-	12	1.68
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-8.66
Accounts Receivable, 5 Yr. CAGR %	-	-	-	32.54	14.21
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-24.43	150.58
Total Assets, 5 Yr. CAGR %	-	-	-	-23.73	1.76
Tangible Book Value, 5 Yr. CAGR %	-	-	-	31.46	-40.44
Common Equity, 5 Yr. CAGR %	-	-	-	29.6	-31.46